226 related articles for article (PubMed ID: 30321309)
21. Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.
Jacobshagen C; Grüber M; Teucher N; Schmidt AG; Unsöld BW; Toischer K; Nguyen VP; Maier LS; Kögler H; Hasenfuss G
Eur J Heart Fail; 2008 Apr; 10(4):334-42. PubMed ID: 18343721
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
[TBL] [Abstract][Full Text] [Related]
23. Non-coding RNAs in endothelial cell signalling and hypoxia during cardiac regeneration.
Peters MMC; Sampaio-Pinto V; da Costa Martins PA
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118515. PubMed ID: 31362011
[TBL] [Abstract][Full Text] [Related]
24. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
Hille S; Dierck F; Kühl C; Sosna J; Adam-Klages S; Adam D; Lüllmann-Rauch R; Frey N; Kuhn C
Cardiovasc Res; 2016 Jun; 110(3):381-94. PubMed ID: 27056896
[TBL] [Abstract][Full Text] [Related]
25. Nrg1 is an injury-induced cardiomyocyte mitogen for the endogenous heart regeneration program in zebrafish.
Gemberling M; Karra R; Dickson AL; Poss KD
Elife; 2015 Apr; 4():. PubMed ID: 25830562
[TBL] [Abstract][Full Text] [Related]
26. Tbx6 induces cardiomyocyte proliferation in postnatal and adult mouse hearts.
Haginiwa S; Sadahiro T; Kojima H; Isomi M; Tamura F; Kurotsu S; Tani H; Muraoka N; Miyake N; Miyake K; Fukuda K; Ieda M
Biochem Biophys Res Commun; 2019 Jun; 513(4):1041-1047. PubMed ID: 31010673
[TBL] [Abstract][Full Text] [Related]
27. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
28. [Myocardial regeneration: proliferative potential of cardiomyocytes and induction of cardiomyogenesis in alterative and plastic cardiac failure].
Nepomniashchikh LM; Lushnikova EL; Larionov PM; Shurygin MG
Vestn Ross Akad Med Nauk; 2010; (5):3-11. PubMed ID: 20614514
[TBL] [Abstract][Full Text] [Related]
29. Sucrose Nonfermenting-Related Kinase Enzyme-Mediated Rho-Associated Kinase Signaling is Responsible for Cardiac Function.
Cossette SM; Bhute VJ; Bao X; Harmann LM; Horswill MA; Sinha I; Gastonguay A; Pooya S; Bordas M; Kumar SN; Mirza SP; Palecek SP; Strande JL; Ramchandran R
Circ Cardiovasc Genet; 2016 Dec; 9(6):474-486. PubMed ID: 27780848
[TBL] [Abstract][Full Text] [Related]
30. Small and long non-coding RNAs in cardiac homeostasis and regeneration.
Ounzain S; Crippa S; Pedrazzini T
Biochim Biophys Acta; 2013 Apr; 1833(4):923-33. PubMed ID: 22951218
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition.
Murphy E; Steenbergen C
Expert Opin Ther Targets; 2005 Jun; 9(3):447-56. PubMed ID: 15948666
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
33. Endogenous Mechanisms of Cardiac Regeneration.
Xiang MS; Kikuchi K
Int Rev Cell Mol Biol; 2016; 326():67-131. PubMed ID: 27572127
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic potential of H11 kinase for the ischemic heart.
Danan IJ; Rashed ER; Depre C
Cardiovasc Drug Rev; 2007; 25(1):14-29. PubMed ID: 17445085
[TBL] [Abstract][Full Text] [Related]
35. Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.
Qiu XX; Liu Y; Zhang YF; Guan YN; Jia QQ; Wang C; Liang H; Li YQ; Yang HT; Qin YW; Huang S; Zhao XX; Jing Q
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971953
[TBL] [Abstract][Full Text] [Related]
36. Medicinal Chemistry Approaches to Heart Regeneration.
Schade D; Plowright AT
J Med Chem; 2015 Dec; 58(24):9451-79. PubMed ID: 26288266
[TBL] [Abstract][Full Text] [Related]
37. Cardiomyocyte Proliferation for Therapeutic Regeneration.
Leach JP; Martin JF
Curr Cardiol Rep; 2018 Jun; 20(8):63. PubMed ID: 29904823
[TBL] [Abstract][Full Text] [Related]
38. Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.
Gupte M; Tumuluru S; Sui JY; Singh AP; Umbarkar P; Parikh SS; Ahmad F; Zhang Q; Force T; Lal H
Int J Cardiol; 2018 May; 259():145-152. PubMed ID: 29398139
[TBL] [Abstract][Full Text] [Related]
39. GSK-3β Inhibitor CHIR-99021 Promotes Proliferation Through Upregulating β-Catenin in Neonatal Atrial Human Cardiomyocytes.
Wang S; Ye L; Li M; Liu J; Jiang C; Hong H; Zhu H; Sun Y
J Cardiovasc Pharmacol; 2016 Dec; 68(6):425-432. PubMed ID: 27575008
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration.
Yester JW; Kühn B
Curr Cardiol Rep; 2017 Feb; 19(2):13. PubMed ID: 28185170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
